Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize

• Michal Kýr,
• Michal Kýr,
• Giannoula Lakka Klement,
• Giannoula Lakka Klement,
• Giannoula Lakka Klement,
• Lenka Zdrazilova-Dubska,
• Lenka Zdrazilova-Dubska,
• Regina Demlova,
• Regina Demlova,
• Dalibor Valik,
• Dalibor Valik,
• Dalibor Valik,
• Ondrej Slaby,
• Ondrej Slaby,
• Irene Slavc,
• Jaroslav Sterba,
• Jaroslav Sterba

Affiliations

Michal Kýr

Department of Pediatric Oncology, University Hospital Brno, Brno, Czechia

Michal Kýr

Faculty of Medicine, Masaryk University, Brno, Czechia

Giannoula Lakka Klement

Department of Pediatric Oncology, University Hospital Brno, Brno, Czechia

Giannoula Lakka Klement

CSTS Health Care, Toronto, ON, Canada

Giannoula Lakka Klement

Floating Hospital for Children at Tufts Medical Center, Boston, MA, United States

Lenka Zdrazilova-Dubska

Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czechia

Lenka Zdrazilova-Dubska

Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czechia

Regina Demlova

Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czechia

Regina Demlova

Department of Clinical Trials, Masaryk Memorial Cancer Institute, Brno, Czechia

Dalibor Valik

Department of Pediatric Oncology, University Hospital Brno, Brno, Czechia

Dalibor Valik

Department of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czechia

Dalibor Valik

Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czechia

Ondrej Slaby

Department of Pathology, University Hospital Brno, Brno, Czechia

Ondrej Slaby

Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czechia

Irene Slavc

0Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

Jaroslav Sterba

Department of Pediatric Oncology, University Hospital Brno, Brno, Czechia

Jaroslav Sterba

Faculty of Medicine, Masaryk University, Brno, Czechia